STRATEC Biomedical AG
Abrir
17.36 1.64
Visão Geral
Variação de preço das ações
24h
Mín
16.68
Máximo
17.68
Rendimento | 2.6M -1.7M |
|---|---|
Vendas | -22M 53M |
P/E Médio do Setor | 14.63 30.136 |
EPS | -0.357 |
Rendimento de Dividendos | 3.3 |
Margem de lucro | -3.206 |
Funcionários | 1,395 |
EBITDA | -6.7M 4.1M |
Recomendações | Comprar |
|---|---|
Previsão para 12 meses | +55.9% upside |
Rendimento de Dividendos Médio do Setor | 3.30% 3.27% |
|---|---|
Próximos Ganhos | 14 de ago. de 2026 |
Capitalização de Mercado | 6.8M 221M |
|---|---|
Abertura anterior | 15.72 |
Fecho anterior | 17.36 |
STRATEC Biomedical AG Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
